BIO-RAD LABORATORIES-A (BIO)
US0905722072 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Change In Working Capital | 116.91M | 108.26M | 85.80M | 47.80M | 18.10M | |||
| Interest Paid | -47.41M | -47.49M | -24.40M | -2.30M | -21.60M | |||
| Taxes Paid | -120.13M | -129.59M | -158.30M | -134.70M | -65.20M | |||
| OPERATING CASH FLOW | 346.63M | 374.94M | 194.40M | 669.50M | 585.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -161.16M | -156.68M | -112.80M | -133.70M | -108.60M | |||
| Other Investing Activity | 208.67M | 176.89M | -1.09B | -663.60M | 38.70M | |||
| INVESTING CASH FLOW | 47.62M | 20.21M | -1.21B | -797.40M | -69.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -485.00K | -467.00K | 1.19B | -3.00M | -426.90M | |||
| Stock Issued/Repurchased | N/A | -410.24M | -198.10M | -29.40M | -79.80M | |||
| Other Financing Activity | -19.95M | -14.94M | -14.00M | -23.00M | -16.30M | |||
| FINANCING CASH FLOW | -429.93M | -425.65M | 973.60M | -55.40M | -523.00M | |||
| Exchange Rate Effect | 4.98M | 321.00K | 3.00M | -12.60M | 12.40M | |||
| CHANGE IN CASH | -30.69M | -30.18M | -36.60M | -195.90M | 4.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 346.63M | 374.94M | 194.40M | 669.50M | 585.00M | |||
| Capital Expenditure | -161.16M | -156.68M | -112.80M | -133.70M | -108.60M | |||
| FREE CASH FLOW | 185.48M | 218.26M | 81.60M | 535.80M | 476.40M | |||
All data in USD